Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation

Published:2016-11 Issue:11 Volume:22 Page:1319-1329
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Brown Joshua D.¹,Shewale Anand R.²,Talbert Jeffery C.¹

Affiliation:

1. Institute for Pharmaceutical Outcomes & Policy, Department of Pharmacy Practice & Science, University of Kentucky College of Pharmacy, Lexington, Kentucky.

2. Division of Pharmaceutical Evaluation & Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States;Expert Review of Pharmacoeconomics & Outcomes Research;2024-09-03

2. Group-based trajectory modeling to identify adherence patterns for direct oral anticoagulants in Medicare beneficiaries with atrial fibrillation: a real-world study on medication adherence;International Journal of Clinical Pharmacy;2024-08-27

3. Group-Based Trajectory Modeling to Identify Adherence Patterns for Direct Oral Anticoagulants in Medicare Beneficiaries with Atrial Fibrillation;2024-02-13

4. Utilization outcomes of direct oral anticoagulants in Medicare patients;Research in Social and Administrative Pharmacy;2023-11

5. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN‐SPIDERS;British Journal of Clinical Pharmacology;2022-05-22